VivoSim Labs Inc

Finanzen von VivoSim Labs Inc (VIVS)

$0.285

-0.008 (-2.63%)Zum Schluss

Profitabilität und Margen von VIVS

Evaluating the bottom line, VivoSim Labs Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -15327.78%, while the net margin is -7433.33%. These profitability ratios, combined with a Return on Equity (ROE) of -343.10%, provide a clear picture of how effectively VIVS converts its operational activities into shareholder value.

VIVS im Vergleich zur Peergroup

In the context of the broader market, VIVS competes directly with industry leaders such as PPCB and ELAB. With a market capitalization of $4.79M, it holds a leading position in the sector. When comparing efficiency, VIVS's gross margin of N/A stands against PPCB's N/A and ELAB's 7.99%. Such benchmarking helps identify whether VivoSim Labs Inc is trading at a premium or discount relative to its financial performance.

Finanzielle Entwicklung von VivoSim Labs Inc

VivoSim Labs has shown inconsistent financial performance, with total revenue fluctuating and a significant net loss of -$5,764,000 in Q4 2026. The gross margin remains high at 100%, but the overall financial health is concerning due to the negative net income and equity.

Financials

FY2027Q1
YoY:
-51.35%
18.00K
Total Revenue
FY2027Q1
YoY:
-5.35%
-2.76M
Operating Profit
FY2026Q4
YoY:
-184.12%
-5.76M
Net Income after Tax
FY2027Q1
YoY:
-77.19%
-0.26
EPS - Diluted
FY2027Q1
YoY:
-17.87%
-3.24M
Free Cash Flow
FY2026Q4
YoY:
0.00%
100.00
Gross Profit Margin - %
FY2027Q1
YoY:
+23.04%
-9.04K
FCF Margin - %
FY2027Q1
YoY:
-3.26%
-7.43K
Net Margin - %

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten